Anavex Life Sciences
AVXL
#7563
Rank
โ‚น35.31 B
Marketcap
โ‚น395.28
Share price
-1.12%
Change (1 day)
-38.58%
Change (1 year)

Market capitalization of Anavex Life Sciences (AVXL)

Market cap: โ‚น35.31 Billion

As of December 2025 Anavex Life Sciences has a market cap of โ‚น35.31 Billion. This makes Anavex Life Sciences the world's 7563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Anavex Life Sciences from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น35.31 B-59.92%
2024โ‚น88.11 B38.5%
2023โ‚น63.62 B6.5%
2022โ‚น59.73 B-39.11%
2021โ‚น98.11 B271%
2020โ‚น26.44 B150.84%
2019โ‚น10.54 B106.13%
2018โ‚น5.11 B-43.75%
2017โ‚น9.09 B-14.71%
2016โ‚น10.65 B-16.9%
2015โ‚น12.82 B1896.21%
2014โ‚น0.64 B10.53%
2013โ‚น0.58 B-55.56%
2012โ‚น1.30 B-25.45%
2011โ‚น1.75 B-57.31%
2010โ‚น4.10 B96.05%
2009โ‚น2.09 B-15.24%
2008โ‚น2.47 B-39.15%
2007โ‚น4.06 B77%
2006โ‚น2.29 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Anavex Life Sciences was reported to be:

โ‚น35.31 Billion
by Nasdaq info icon info icon
โ‚น35.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น326.87 B 825.53%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น143.56 B 306.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น815.08 B 2,207.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น3.51 B-90.04%๐Ÿ‡บ๐Ÿ‡ธ USA